SUBSTITUTED PYRROLOPYRIDINES

摘要

There are provided novel compounds of formula (I) wherein R<1>, R<2> and R<3> are as defined in the specification and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of the kinase Itk.